THE BULKING AGENT WITH LONG-LASTING EFFECT!

Similar documents
THE LONG-TERM SOLUTION FOR MALE INCONTINENCE

THE WOMAN-FRIENDLY STERILIZATION METHOD

Physician Training Manual for Urolastic

BULKAMID STANDARD OPERATING PROCEDURE

Blue Ridge Urogynecology

This information is intended as an overview only

A PATIENT GUIDE TO Understanding Stress Urinary Incontinence

q7:480499_P0 6/5/09 10:23 AM Page 1 WHAT YOU SHOULD KNOW ABOUT YOUR DIAGNOSIS OF STRESS URINARY INCONTINENCE

What you should know about your diagnosis of incontinence

Desara TV and Desara Blue TV

Periurethral bulking injections for stress urinary incontinence

Bard: Continence Therapy. Stress Urinary Incontinence. Regaining Control. Restoring Your Lifestyle.

AMS 800 Urinary Control System ACTIVATING:

Tension-free Vaginal Tape (TVT)

3. Urinary Catheters. Indications. Methods of Bladder Catheterization. Hashim Hashim

URINARY INCONTINENCE

AMS 800 Urinary Control System

Tension Free vaginal tape. Mrs Ami Shukla, Consultant Urogynaecologist Northampton General Hospital Northampton NN1 5BD

Portable Bladder Ultrasound. OHTAC Recommendation. Portable Bladder Ultrasound

MACROPLASTIQUE IMPLANTS

MP A Prospective Evaluation of the Catheter Science M3 Mini Catheter for Patients with Prostatic Obstruction. Gaines W. Hammond Jr.

Stress Urinary Incontinence in Women. What YOU can do about it...

Flexible Cystoscopy. Patient Information

Advanced Care for Female Overactive Bladder & Urinary Incontinence. Department of Urology Kaiser Permanente Santa Rosa

Injection of Urethral Bulking Agents

You have been booked for a. Flexible Cystoscopy. Under Local Anaesthetic

Surgical treatment of urinary stress incontinence with tension free vaginal tape

A minimally invasive treatment for stress urinary incontinence

Women s & Children s Directorate The TVT Operation - a guide for patients

Evidence Summary: The inflow Urinary Prosthesis FDA De Novo Approval DEN130044

THE UROLOGY GROUP

This course is all about solving the medical emergency of difficult or failed urethral catheterisation, which in most cases happens in elderly men

Desara and Desara Blue

SOP: Urinary Catheter in Dogs and Cats

Urinary Incontinence

A Simple Solution. to a Common Problem. Find relief from sudden, unplanned urine leakage.

Suprapubic Catheter Insertion Clinic

Suprapubic Catheter Insertion Clinic

Loss of Bladder Control

KRUUSE Urinary Catheters

Incontinence. Anatomy The human body has two kidneys. The kidneys continuously filter the blood and make urine.

Rezūm procedure for the Prostate

Glossary of terms Urinary Incontinence

PROSTATIC ARTERY EMBOLISATION (PAE) FOR BENIGN PROSTATIC HYPERPLASIA. A Minimally Invasive Innovative Treatment

Double j stent modification and replacement to avoid secondary auxiliary procedure for its removal

Instruction For Use for All Silicon Foley Catheter

Loss of Bladder Control

Intermittent self-catheterisation (ISC) Information for patients Spinal Injuries

Families Unit Division

PATIENT SELECTION GUIDE. finding the right fit

CYSTOCELE REPAIR PROCEDURE EDUCATION LITERATURE AND CONSENT FORM

Bulkamid. Patient Information. Obstetrics & Gynaecology Department

Male and Female Catheterisation

Bladder neck bulking injection. Information for patients Gynaecology

Patient Information Leaflet

AMSure UROLOGICAL CARE

Sacral Nerve Stimulation (SNS) System Implantation

Cystoscopy and urethroscopy

Using PDSA Cycles to Implement CAUTI Bundles and Transfer Communication between Settings

Voiding Diary. Begin recording upon rising in the morning and continue for a full 24 hours.

Intermittent Self-Catheterization

Purpose. Policy Statement. Principles. Applicability. Responsibility

BIOPSY GUN. Delivered in sterile peel-open package. Device is made of Stainless Steel and PP material.

Urinary Catheter or Urinary Tract Infection Critical Element Pathway

Complication of long indwelling urinary catheter and stent COMPLICATION OF LONG INDWELLING URINARY CATHETER AND STENT

Unit Title: Urinary Catheterisation

CYSTOSCOPY & TRANSURETHRAL RESECTION OF THE PROSTATE

Procedure for removal and reinsertion of an indwelling urethral catheter (female)

P ROLIEVE. Thermodilatation System. The Prolieve System Patient Information is Directed to You, the Patient. A Transurethral Microwave Therapy Device

Urinary Incontinence. Biopolymer GmbH & Co.KG - Germany

Continuous Bladder Irrigation

relieve pressure on the lungs treat symptoms such as shortness of breath and pain determine the cause of excess fluid in the pleural space.

Procedure for removal and reinsertion of a supra pubic catheter

EMR template and postprocedure notes

One Slim Needle One Incision. One Simple Solution for Stress Urinary Incontinence. The Difference is in the Data

Pelvic Prolapse. A Patient Guide to Pelvic Floor Reconstruction

Clean Intermittent Self-Catheterisation (CISC)

Cryotherapy for localised prostate cancer

Ureteral Stenting and Nephrostomy

1) What conditions is vaginal mesh used to commonly treat? Vaginal mesh is used to treat two different health issues in women:

Cystoscopy. Your cystoscopy is scheduled at the Ambulatory Procedure Center at Altru Clinic - Main, 4-south waiting room.

Symptoms, Diagnosis and Classification

Endoscopy. Flexible Cystoscopy. Information

OVER 70% OF MEN IN THEIR 60s HAVE SYMPTOMS OF BPH 1

Stress Urinary Incontinence in Women

Patient Information. Prostate Tissue Ablation. High Intensity Focused Ultrasound for

MANAGEMENT OF THE BLADDER IN THE POSTOPERATIVE PERIOD FOLLOWING UNCOMPLICATED GYNAECOLOGICAL SURGERY CLINICAL GUIDELINES

Loss of Bladder Control

Patient Information. Tension Free Vaginal/ Obturator Tape (TVT) Royal Devon and Exeter NHS Foundation Trust

UNDERSTANDING RADIOACTIVE SEED IMPLANTS

Percutaneous nephrolithotomy (PCNL)

Medical Review Criteria Invasive Treatment for Urinary Incontinence

INCONTINENCE AND OTHER UROLOGICAL DILEMMAS DR. ANNA LAWRENCE UROLOGIST AUCKLAND HOSPITAL 161 UROLOGY

6 Page Male Incontinence Booklet 10/09/ :44 Page 1. The Natural Non-Surgical Option for Male Urinary Incontinence

Incontinence. Urinary. In Adults. THIS PUBLICATION IS OUT OF DATE. For most current information:

Children's (Pediatric) PICC Line Placement

Policy #: 213 Latest Review Date: September 2012

Management of Female Stress Incontinence

Collection of Specimen

Mrs Maya Harris Consultant Urologist INDWELLING CATHETERS: COMPLICATIONS AND SOLUTIONS

Transcription:

THE BULKING AGENT WITH LONG-LASTING EFFECT! Urogyn BV Transistorweg 5a 6534 AT Nijmegen The Netherlands t +31(0) 24 711 41 30 info@urogynbv.com www.urogynbv.com

THE FIRST INJECTABLE IMPLANT THAT CAN COMPETE WITH SLINGS LONG-LASTING Unlike most other bulking agents Urolastic is not biodegradable. It does not shrink and maintains its volume. This makes Urolastic a long-lasting solution for stress urinary incontinence (SUI). NO MIGRATION Urolastic is easy to inject and polymerizes in situ into a uniform biocompatible elastomer within seconds after application. It remains flexible and adapts to its environment, reducing the chances of migration. REMOVABLE Urolastic is visible using ultrasound or X-ray. The implant shows no in-growth of tissue and can therefore be removed easily if required. OUTPATIENT PROCEDURE Urolastic is used in an outpatient, minimally invasive procedure under local anesthesia and requires only limited assistance. Urolastic is a trademark of Urogyn bv. rev.0 2

ADVANTAGES FOR USING THE UROLASTIC PROCEDURE FAST PROCEDURE, NO OPERATING ROOM REQUIRED. LESS STRESS FOR PATIENTS, NO NARCOSIS, NO INCISIONS. MOST PATIENTS CAN GO HOME THE SAME DAY AND RESUME THEIR ACTIVITIES. PERI-URETHRAL INJECTION SO NO DAMAGE OF THE URETHRAL MUCOSA. UROLASTIC IS EFFECTIVE IN BOTH PRIMARY AND SECONDARY PATIENTS (e.g. AFTER SLING PROCEDURES) THE EFFECT OF THE TREATMENT CAN BE OBSERVED IMMEDIATELY AFTER THE PROCEDURE. RETENTION AS A CONSEQUENCE OF THE UROLASTIC PROCEDURE CORRECTED. IS EASILY 3

NECESSARY EQUIPMENT THE UROLASTIC KIT THE UROLASTIC KIT CONTAINS: 1. Dispenser gun for the dual syringe. 2. Pre-filled 5 ml dual syringe with a lock fitting, containing 2 x 2.5 ml (1:1) Urolastic elastomer composition. 3. Static mixer with needle 1.20 x 50mm (18G x 2 ) attached and co-packed with the syringe in a blister. 4. Three Urolastic applicators, one of which is selected during the Urolastic procedure for inserting the needle at specific places in the midurethral section. 5. Instruction for use. 6. Patient labels (3). OPTIONAL: Applicator supports to replace the cystoscope in blind procedures (these are supplied separately). AUXILIARY MATERIALS TO BE PROVIDED BY THE HOSPITAL 1. Local anesthetic (lidocaine with adrenaline 1% or similar) and syringe for injection. 2. A pair of tweezers. 3. A Foley catheter and inserting gel. 4. A 50-100 ml disposable syringe. 5. Sterile water for irrigation (250-300 ml). 6. Sterile gauzes. 7. Standard disinfectant solution. 8. Sterile cups. 9. Ruler. Urolastic is a trademark of Urogyn bv. rev.0 4

PRE-OPERATIVE PROCEDURES Prior to treatment, the patient must undergo a physical examination and thorough evaluation to ensure proper patient selection. The Urolastic procedure is straightforward and may be performed as an outpatient procedure under local anesthesia. Compared to pubo-vaginal sling procedures, there is little risk of post-operative urinary retention. The patient s urine should be tested in advance to exclude urinary tract infection (UTI). One dose of oral antibiotic (Ciprofloxacin, 500 mg) and one dose of oral NSAID should be given at the start of the procedure. Prepare for routine cystoscopy; if the procedure is done under local anesthesia, the patient is asked to cough to demonstrate stress urinary incontinence. The condition of the tissue must be evaluated (e.g. hardness, edema, hematoma, atrophy) at the site of injection prior to treatment. Consider estrogen treatment prior to the Urolastic procedure in patients who need tissue improvement. Place the patient in lithotomy position. Disinfect according to local routine procedure. Inject 4x 1ml lidocaine 1% or similar, bilaterally to the mucosa along the urethra. Wait 5 10 minutes before starting the Urolastic procedure. 5

THE PROCEDURE figure 1 MEASURING THE LENGTH OF THE URETHRA A balloon catheter is used to accurately measure the length of the urethra. CHOOSE THE RIGHT APPLICATOR The applicators or needle guides are designed to place the deposits in a concentric ring around the mid-urethral section. It is very important to choose the correct applicator. FILLING OF THE BLADDER The balloon catheter is used to fill the bladder with water until the patient starts feeling the urge to void (normally about 200 ml). The cough test should be positive. If it isn t, verify that the patient was diagnosed for stress incontinence. PLACING THE DEPOSITS (figure 1) The dispenser gun combined with syringe, static mixer and needle is prepared. The applicator is placed in the meatus with the needle holes in the required position. Using the applicator, deposits are placed in the 2, 5, 10 and 7 o clock positions. COUGH TEST The cough test should be negative. If some leakage persists, an extra deposit is placed in either the 9 or 3 o clock position. figure 2 END OF PROCEDURE (figure 2) The puncture holes are cleared of any material that is sticking out. The correct placement of the implants is checked by palpation. The patient is asked to stay in the hospital until she is able to void independently. Urolastic is a trademark of Urogyn bv. rev.0 6

POST OPERATIVE PROCEDURE WHAT HAPPENS AFTER THE PROCEDURE? In case of voiding difficulties, nursing staff responsible for postoperative care should be clearly instructed not to use any catheter with a diameter larger than 12G. Intermittent catheterization is carried out until patients resume spontaneous voiding. Patients are discharged after complete residue free voiding. If patients need to be catheterized for more than 7 days, consider removing one of the deposits at either the 5 or 7 o clock position. The implant can be felt from the vaginal side. A small incision is made and the implant is removed using a pair of tweezers. This usually solves the problem. PRECAUTIONS 1. Patients should refrain from doing any heavy lifting or exercise for 4 to 6 weeks to allow for encapsulation of the implant with connective tissue. 2. Patients should be informed that for the first few hours, and sometimes days, they may experience a bruised feeling at the injection sites. 3. Patients with former sling procedures may receive Urolastic treatment. Also, Urolastic deposits will not prevent later sling procedures if indicated. 7

ARE YOU INTERESTED IN BECOMING A CERTIFIED UROGYN PRACTITIONER? Urogyn offers training, free of charge, to doctors interested in conducting procedures, provided by experienced colleagues. Interested doctors will receive a training certificate after three successfully performed procedures. Primary patients or patients who have previously received treatment yet remained incontinent may be recruited for these training purposes. Doctors may train at their own hospital or at the hospital of a colleague, where they can bring their own patients. Training may also be given abroad. If you would like more information about training, or if you would like to attend a procedure performed by a trained colleague, please send us an email at info@urogynbv.com. Urolastic is a trademark of Urogyn bv. rev.0 8

WHAT DO WE OFFER? A very cost effective procedure Free training provided by experienced colleagues Training either at your hospital or at a hospital nearby Training manual Training certificate after 3 successfully performed procedures VISIT OUR WEBSITE: www.urogynbv.com CONTACT US: info@urogynbv.com For more information regarding clinical data, please go to: www.urogynbv.com/clinical-data 9

Urolastic is a trademark of Urogyn bv. rev.0 PROGRESS THROUGH INNOVATION!